Multiple Myeloma Treatment in India
About Multiple Myeloma
Multiple myeloma is the second most common type of blood cancer. Also known as Myeloma, it starts in the plasma cells of the bone marrow. Plasma cells are short lived antibody (protein) producing cells, derived from a type of white blood cell (B-Lymphocyte). They make different forms of proteins (antibody) that helps fight infection. Malignant transformation of plasma cells results in defective and abnormal single protein formation called monoclonal or M protein. When plasma cells become cancerous and grow out of control, they produce a tumor called plasmacytoma. If someone has only a single plasma cell tumor, the disease is called solitary plasmacytoma or if someone has more than one plasmacytoma, it is called multiple myeloma.Risk Factors:
There is no exact cause known for the disease. However there are few risk factors associated with increased risk of multiple myeloma, these include:
Age factor: More common in elder people.
Gender: Males are more likely to get multiple myeloma than female.
Family History: If someone is having family history of multiple myeloma, he or she is 4 times more likely to develop multiple myeloma compared to others.
Though not proved, but People who have suffered from some kind of injury are also prone to get multiple myeloma.
Few other plasma cell diseases like solitary plasmacytoma or Monoclonoal gamopathy of unknown significance are associated with high risk for developing multiple myeloma.
Comments
Post a Comment